...on UHG. It’s time to sell off businesses and refocus on either being an insurer or being a healthcare services company. Not both. If UHG chooses to be an insurer, refocus on a service mission, not the shareholders. Respect their members (and commercial businesses) who pay the premiums. Focus on member health, first preventative, then managing chronic care. Stop treating patients and providers as always trying to game the system or grift them. People depend on insurance at the time of need, when they are sick, and treatment is complicated. Make it easier for both members and their providers. Bring... Continue Reading
Search Results for chronic traumatic encephalopathy
Short takes: Synchron BCI integrates with Apple devices, Shields Health partners with Duke on specialty pharmacy, raises for Cohere Health, Olio
...solutions, enabling Duke to support patients with complex chronic conditions through regular follow-ups, side effect management, financial assistance, and medication delivery, with the goals of better medication adherence and patient outcomes. Shields partners with nearly 80 health systems, providing access to over 80% of limited distribution drugs (LDDs) and with most payers. Their clinical model is designed to reduce the total cost of care by 13%. Release Two raises of note this week (are we seeing the return of lettered rounds?): Cohere Health lands a $90 million Series C raise. The round was led by by Temasek, with continued support... Continue Reading
News roundup: Omada Health files for IPO, UPMC-Redesign partner on chronic pain management, OK and PA AGs warn 23andMe users to delete data, Verily to build Parkinson’s dataset, what payers paid for exec security
...from $19 million in Q1 2024. CNBC, Mobihealthnews, FierceHealthcare Larger and MSK-focused competitor Hinge Health announced its own IPO back in mid-March [TTA 14 Mar] via a SEC S-1 filing and preliminary prospectus, but sent out word that it was postponing by April [TTA 8 April]. With markets doing much better, it’s anticipated that their debut on the NYSE will be this summer. Their funders which have invested over $826 million since 2012 are undoubtedly eager for ROI. The Redesign Health-UPMC Enterprises partnership launches Glimmer Health. The new company supports primary care physicians to manage their patients’ chronic pain. Chronic... Continue Reading
News roundup: WeightWatchers in 45-day prepackaged Ch. 11, Neuralink BCI successful in ALS subject, telehealth VR reduced TMD pain–study, AliveCor maxes up KardiaMobile 6L, TytoCare-Allina Health partnership, UHG-Amedisys divest some more
...Mobihealthnews, RedState The previous recipients, Noland and Alex, are both paraplegics[TTA 21 Feb 2024]. Next up is Blindsight, which Elon Musk has said that will be tested in humans by the end of 2025 [TTA 10 Apr]. There is also a Canadian clinical trial, the “Canadian Precise Robotically Implanted Brain-Computer Interface” (CAN-PRIME) for subjects with tetraparesis or tetraplegia resulting from cervical spinal cord injury or the neurological disease ALS [TTA 27 Nov 2024]. A competitor of Neuralink, Precision Neuroscience, closed a Series C at $102 million last December. A telehealth virtual reality (VR) solution effective for reducing chronic pain. A... Continue Reading
Product & funding very short takes: South Australia 1st with Sunrise EMR; S. Korea pain research, new emergency services app; BCI + telehealth for stroke patients; VirtuSense monitoring launches at Emory; Series B raises for Nourish, Healthee
...this year. VSTOne uses LIDAR (Light Detection and Ranging) technology in patient rooms to detect falls, continuous monitoring of patient data to anticipate deterioration or emergencies, and care staff to call directly into patient rooms to expedite admission, discharge, and general documentation. At Emory, it integrates with Epic MyChart Bedside TV. Release In company fundings: In the burgeoning ‘food as medicine’ segment, Nourish raised $70 million in a Series B funding round. Nourish works with national commercial, Medicare, and Medicaid plans to better manage and guide those with chronic conditions through nutrition. Users work virtually with registered dietitians along with... Continue Reading
News roundup: Walgreens’ $350M opioid settlement, only 30% of healthcare AI pilots reach production, Medicare RPM usage up 10-fold despite benefit limitations
...segments. Remote patient monitoring (RPM) Medicare usage growing steadily, despite limitations on clinical effectiveness. This new report from the Peterson Center on Healthcare tracks how RPM usage has grown among Medicare (traditional, Medicare Advantage) and Medicaid beneficiaries since 2019, when CMS enabled Medicare codes for reimbursement. For Medicare, despite only 1% of beneficiaries using RPM, it grew exponentially–10-fold for traditional Medicare between 2019-2023 and 14-fold for MA between 2019 and 2022. Top chronic conditions are hypertension (57%) with diabetes far behind at 13%. Also growing but much smaller is remote therapeutic monitoring (RTM), dominated by musculoskeletal (MSK) disorders. Traditional Medicare... Continue Reading
Perspectives: Bridging the Gap in Rural Healthcare Through Telehealth
...of rural hospital closures has far-reaching implications. For many residents, these facilities provide not only emergency care but also routine health services, chronic disease management, and preventive screenings. With the loss of a nearby hospital, patients are often forced to travel long distances for care—a situation that can delay treatment and exacerbate health conditions. Additionally, the closure of rural hospitals often leads to increased pressure on remaining facilities, further straining resources and limiting access. Telehealth, which allows patients to connect with healthcare providers through digital platforms, offers a promising solution to these challenges. By enabling virtual consultations, remote monitoring, and... Continue Reading
Are Hippocratic AI and AI “nurses” the wave of the future–or just another tide of hype? Two articles question.
Two Gimlety views of a hot AI player, Hippocratic AI. 2025’s first $1.6 billion valuation unicorn after its January $141 million Series B venture round is on a hiring streak. Their ‘safety focused generative AI for healthcare’ built on large language models (LLMs) has developed multi-age, ethnicity, and language AI-powered virtual “nurses” to interact with patients on post-discharge follow ups for medical and hospital visits, chronic care management, and medication reminders. The purpose of the agentic AI nurses is to close the gap of healthcare staff shortages. On their website, the recorded demos of the ‘nurses’ roleplaying with real nurses... Continue Reading
Short takes: interesting takeaways from the Veradigm earnings call, VA cuts ~6 EHRM contracts; mergers for DispatchHealth-Medically Home, Wysa-April Health
...employers, while April Health partners with primary care providers for behavioral care management with live managers. The Wysa chatbot in 2022 received FDA Breakthrough Device Designation for use by patients 18 years old and older with a diagnosis of chronic musculoskeletal pain, depression and anxiety. April Health has already integrated the Wysa chatbot with its services for LifePoint Healthcare and The Newton Clinic (affiliated with MercyOne). Terms of the transaction, headquarters location, and management transitions are not disclosed. Wysa has raised about $35 million in funding, with the last round in 2023, while April Health has seed funding only. Release,... Continue Reading
Perspectives: Telehealth Expands Access to Addiction Treatment and Specialized Care, But Navigating Regulations Remains Key
...Telehealth’s really made a huge difference in who can get good medical care. By enabling health system leaders to connect more patients to doctors, 91% now report having a telehealth program in place. Even so, accessibility to prescriptions and proper healthcare remains a critical issue in the US. A systematic review of 185 studies found that 54% of cases indicated how disability or chronic health conditions create barriers to medication access. Race contributed to 28% of reported barriers, while income and education levels were factors in 30% of the studies. Furthermore, half identified a lack of available treatment or healthcare... Continue Reading
Most Recent Comments